ライフサイエンスコーパス: mononucleosis

1 13 patients presenting with sore throat has mononucleosis).

2 , defined as flu-like symptoms or infectious mononucleosis).

3 D4(+) and CD8(+) T cells in acute infectious mononucleosis.

4 t of uncomplicated or complicated infectious mononucleosis.

5 uent establishment of latency and infectious mononucleosis.

6 and Mig protein than tissues with infectious mononucleosis.

7 lization, and office diagnosis of infectious mononucleosis.

8 g diagnosed of Epstein-Barr virus infectious mononucleosis.

9 with its associated high risk of infectious mononucleosis.

10 l people who have not experienced infectious mononucleosis.

11 lescence was largely explained by infectious mononucleosis.

12 s reported in patients with acute infectious mononucleosis.

13 confirmed Epstein-Barr virus (EBV) positive mononucleosis.

14 s associated with an increased likelihood of mononucleosis.

15 c symptoms, or have self-limiting infectious mononucleosis.

16 y, specificity, and LRs for the diagnosis of mononucleosis.

17 limit EBV replication and prevent infectious mononucleosis.

18 g diagnosed of Epstein-Barr virus infectious mononucleosis.

19 D25 is absolutely required for CD8(+) T cell mononucleosis.

20 om are seen only in patients with infectious mononucleosis.

21 ith the incidence and severity of infectious mononucleosis.

22 irologic evaluations during acute infectious mononucleosis.

23 mmaglobulenemia without an episode of severe mononucleosis.

24 of the human population, causing infectious mononucleosis(1), susceptibility to autoimmune diseases(

25 Of these, 77% had infectious mononucleosis, 12% had atypical symptoms, and 11% were a

26 ct size=1.5 x 10(-19); I(2)=43%), infectious mononucleosis (2.17, 1.97-2.39; p=3.1 x 10(-50); I(2)=0%

27 osis, and Epstein-Barr virus/cytomegalovirus/mononucleosis, 30% to 60% of circulating CD8 T cells had

28 ssociated with HIV (28%, 33%) and infectious mononucleosis (33%).

29 rus (EBV), the causative agent of infectious mononucleosis, a self-limiting lymphoproliferative disea

30 c CD4(+) T cells in patients with infectious mononucleosis, a symptomatic manifestation of primary EB

31 ype manifested by severe or fatal infectious mononucleosis, acquired hypogammaglobulinemia and malign

32 atients with EBV invariably results in fatal mononucleosis, agammaglobulinemia, or malignant lymphoma

33 from Chinese children with acute infectious mononucleosis (AIM) and chronic active EBV infection (CA

34 0 individuals followed from acute infectious mononucleosis (AIM) into convalescence (CONV).

35 ecimens was not observed in acute infectious mononucleosis (AIM) patients.

36 cing primary EBV infection (acute infectious mononucleosis [AIM]) and again 6 months later (during co

37 ptomatic primary infection (acute infectious mononucleosis [AIM]).

38 sk factors (immunosuppression and infectious mononucleosis), allergic disease and eczema are risk fac

39 least a year after resolution of infectious mononucleosis, although the clone size is reduced.

40 nt in 66% of patients (12/20 with infectious mononucleosis and 12/16 with tonsillar hyperplasia).

41 m 20 American children with acute infectious mononucleosis and 16 Swiss children with chronic tonsill

42 Though it is associated with infectious mononucleosis and approximately 200,000 cancers annually

43 Epstein-Barr virus (EBV) causes infectious mononucleosis and can lead to lymphoproliferative diseas

44 s also essential for EBV to cause infectious mononucleosis and cancers, including B lymphocyte-derive

45 ndividuals who developed sporadic infectious mononucleosis and chronic EBV infection.

46 e infections that result in acute infectious mononucleosis and chronic infections that result in lymp

47 ated with prolonged fatigue after infectious mononucleosis and contrast these factors with those that

48 tected at presentation with acute infectious mononucleosis and declined rapidly thereafter.

49 ggest a role for these analogous proteins in mononucleosis and have implications for their use as vac

50 r virus is the causative agent of infectious mononucleosis and infects approximately 90% of the world

51 EBV causes infectious mononucleosis and is associated with B cell lymphomas, e

52 Epstein-Barr virus (EBV) causes infectious mononucleosis and is associated with B cell lymphomas.

53 Epstein-Barr virus (EBV) causes infectious mononucleosis and is associated with cancers in immunoco

54 EBV causes infectious mononucleosis and is associated with certain malignancie

55 Epstein-Barr virus (EBV) causes infectious mononucleosis and is associated with epithelial-cell can

56 Epstein-Barr virus (EBV) causes infectious mononucleosis and is associated with malignancies in hum

57 svirus, is the causative agent of infectious mononucleosis and is associated with many carcinomas.

58 s (EBV) is the causative agent of infectious mononucleosis and is associated with several forms of ca

59 virus (EBV) is the major cause of infectious mononucleosis and is associated with several human cance

60 The ubiquitous EBV causes infectious mononucleosis and is associated with several types of ca

61 s a human herpesvirus that causes infectious mononucleosis and is associated with several types of ca

62 (EBV) is the most common cause of infectious mononucleosis and is associated with the development of

63 ous human herpesvirus that causes infectious mononucleosis and is etiologically associated with malig

64 surveillance, nevertheless causes infectious mononucleosis and is strongly linked to several types of

65 es numerous health risks, such as infectious mononucleosis and lymphoproliferative disorder.

66 s a human herpesvirus that causes infectious mononucleosis and lymphoproliferative malignancies.

67 rus EBV, which is associated with infectious mononucleosis and malignant tumors, harbors many immune-

68 , which is the causative agent of infectious mononucleosis and multiple cancers(5), utilizes a two-pr

69 The hazard ratios of interest for infectious mononucleosis and multiple sclerosis could be assumed to

70 cally significant after excluding infectious mononucleosis and pneumonia.

71 identified an association between infectious mononucleosis and PSC (odds ratio, 12; 95% confidence in

72 en adolescents with CFS following infectious mononucleosis and recovered controls.

73 itous herpesvirus associated with infectious mononucleosis and several tumors.

74 However, the transient mononucleosis and spike in latently infected cells assoc

75 el variants are frequent in acute infectious mononucleosis and tonsillar hyperplasia and identical to

76 onors with acute gastroenteritis, infectious mononucleosis, and Epstein-Barr virus/cytomegalovirus/mo

77 EBV vaccine might help to prevent infectious mononucleosis, and further development of this should no

78 A history of infectious mononucleosis, and high baseline EBV antibody titers are

79 ction is the most common cause of infectious mononucleosis, and persistent infection is associated wi

80 s (anti-EBNA IgG seropositivity), infectious mononucleosis, and smoking showed the strongest consiste

81 hould mirror the relative risk of infectious mononucleosis as a function of sibship constellation.

82 diagnosed with acute EBV-induced infectious mononucleosis, as assessed by semiquantitative RT-PCR an

83 lls and epithelial cells, causing infectious mononucleosis, as well as a number of cancers.

84 anifestations include fatal acute infectious mononucleosis, B-cell lymphoma, and progressive dys-gamm

85 isease who were misdiagnosed with infectious mononucleosis based on false-positive tests for primary

86 up to 5% of the CD8(+) T cells in infectious mononucleosis blood, the strongest latent Ag-specific re

87 blings provide protection against infectious mononucleosis by occasionally preventing delayed primary

88 Early, accurate diagnosis of infectious mononucleosis can help clinicians target treatment, avoi

89 Infectious mononucleosis caused by Epstein-Barr virus (EBV) usually

90 biquitous in humans, is causal to infectious mononucleosis, chronic active EBV infection, and lymphoi

91 id tissues with acute EBV-induced infectious mononucleosis compared to tissues with PTLD and raise th

92 19-year-old female who developed infectious mononucleosis complicated by unilateral empyema.

93 olescents who have recovered from infectious mononucleosis (controls), while certain cytokine network

94 interactions during self-limited infectious mononucleosis could explain how Epstein-Barr virus (EBV)

95 018 for hospital contacts with an infectious mononucleosis diagnosis (n = 23 905) or a multiple scler

96 When fulminant infectious mononucleosis (FIM) was excluded, there was no statistic

97 patients often develop fulminant infectious mononucleosis (FIM), a life-threatening condition marked

98 its clinical presentation: fatal infectious mononucleosis (FIM), lymphomas, and immunoglobulin defic

99 in the clinical syndrome of acute infectious mononucleosis (glandular fever).

100 cal sequelae, including fulminant infectious mononucleosis, hemophagocytic lymphohistiocytosis, lymph

101 developing severe and often fatal infectious mononucleosis, hemophagocytic lymphohistiocytosis, lymph

102 the cause of pathologies such as infectious mononucleosis (IM) and certain cancers.

103 5% of university students develop infectious mononucleosis (IM) annually, and 9-12% meet criteria for

104 5% of university students develop infectious mononucleosis (IM) annually, and 9-12% meet criteria for

105 substantial genetic component in infectious mononucleosis (IM) etiology.

106 Infectious mononucleosis (IM) is an immunopathological disease caus

107 Acute infectious mononucleosis (IM) is associated with altered expression

108 Infectious mononucleosis (IM) is suspected to be associated with in

109 nfrequently, EBV infection causes infectious mononucleosis (IM) or Burkitt lymphoma (BL).

110 e nonswitched memory pool both in infectious mononucleosis (IM) patients undergoing primary infection

111 ose found in healthy individuals, infectious mononucleosis (IM) patients, and 12 PTLD patients bled a

112 nses that, by T cell cloning from infectious mononucleosis (IM) patients, appear skewed toward immedi

113 has suggested that patients with infectious mononucleosis (IM) who are undergoing primary Epstein-Ba

114 Analysis of infectious mononucleosis (IM), a clinical syndrome that can arise d

115 arr virus (EBV) and occurrence of infectious mononucleosis (IM), a cross-sectional study was undertak

116 rus (EBV), the causative agent of infectious mononucleosis (IM), a disease associated with large viru

117 tion later in life often leads to infectious mononucleosis (IM), a febrile illness characterized by a

118 ayed infection is associated with infectious mononucleosis (IM), a febrile illness in which patients

119 n is often asymptomatic or causes infectious mononucleosis (IM), a self-limiting lymphoproliferative

120 irus and its acute manifestation, infectious mononucleosis (IM), are associated with an increased ris

121 on in adolescence can manifest as infectious mononucleosis (IM), as a fatal illness that magnifies th

122 s pathognomonic of EBV-associated infectious mononucleosis (IM), common in young adults.

123 tissues from patients with acute infectious mononucleosis (IM), interfollicular immunoblasts were sh

124 e, which seems identical to human infectious mononucleosis (IM), persists for a further month or more

125 virus (EBV) infections may cause infectious mononucleosis (IM), whereas EBV reactivations in solid o

126 lls (PBMCs) from 26 patients with infectious mononucleosis (IM).

127 included 8 cases of uncomplicated infectious mononucleosis (IM).

128 induces a syndrome comparable to infectious mononucleosis (IM).

129 ct from self-limiting EBV-induced infectious mononucleosis (IM).

130 stein-Barr virus (EBV)-associated infectious mononucleosis (IM).

131 ipheral blood of 13 subjects with infectious mononucleosis (IM).

132 isted of the clinical syndrome of infectious mononucleosis in 7 children; in addition, 10 children de

133 We present a paediatric case of infectious mononucleosis in a 13-year old, manifesting with follicu

134 Infectious mononucleosis in childhood (hazard ratio [HR], 1.98; 95%

135 Infectious mononucleosis in early adulthood was also associated wit

136 s in many respects to EBV-induced infectious mononucleosis in humans.

137 Mononucleosis is most commonly present among patients ag

138 tivities support the concept that infectious mononucleosis is most likely acquired by kissing.

139 The likelihood of mononucleosis is reduced with the absence of any lymphad

140 Infectious mononucleosis is the clinical manifestation of primary i

141 rus (EBV), the causative agent of infectious mononucleosis, is a human herpesvirus associated with ep

142 shes persistent infection, causes infectious mononucleosis, is a major trigger for multiple sclerosis

143 typically presents as persistent infectious mononucleosis-like disease and/or hemophagocytic lymphoh

144 exhibits a reduction in the development of a mononucleosis-like disease in mice, and can protect mice

145 , primary infection with HHV-6 can produce a mononucleosis-like illness and, more rarely, severe dise

146 y of CD4+CD25+ T regulatory cells during the mononucleosis-like phase of this viral infection.

147 even days later, he presented with a febrile mononucleosis-like syndrome associated with dramatic shi

148 Development of an infectious mononucleosis-like syndrome correlates with the establis

149 latency or the development of the infectious mononucleosis-like syndrome in infected mice.

150 th groups developed the prominent infectious mononucleosis-like syndrome that is characteristic of th

151 ere was no PTLD and one case of EBV disease (mononucleosis-like syndrome), which resolved.

152 Like EBV-infected humans with infectious mononucleosis, mice infected with the rodent gammaherpes

153 including chickenpox, shingles, cold sores, mononucleosis, mumps, hepatitis B, plantar warts, positi

154 serum or plasma has been found in infectious mononucleosis, nasopharyngeal carcinoma, posttransplant

155 e for several diseases, including infectious mononucleosis, nonmalignant and malignant lymphoprolifer

156 s involved in determining whether infectious mononucleosis occurs after primary EBV infection may inc

157 These focus on: (i) patients with infectious mononucleosis or its fatal equivalent, X-linked lymphopr

158 of 250 primary-care patients with infectious mononucleosis or ordinary upper-respiratory-tract infect

159 d B cells, isolated from the same infectious mononucleosis patients, to determine whether differences

160 rus (EBV), the causative agent of infectious mononucleosis, persistently infects over 90% of the huma

161 man lymphocryptovirus that causes infectious mononucleosis, persists asymptomatically for life in nea

162 exhibited the characteristic postinfectious mononucleosis phenotype of XLP with hypogammaglobulinemi

163 e of risk reduced after excluding infectious mononucleosis, pneumonia and CNS infection (hazard ratio

164 ly significant after exclusion of infectious mononucleosis, pneumonia, and CNS infection (hazard rati

165 ociation is explained entirely by infectious mononucleosis, pneumonia, and CNS infections.

166 k cannot be entirely explained by infectious mononucleosis, pneumonia, or CNS infections.

167 that indicates that a history of infectious mononucleosis predisposes to HL.

168 persistent infection, along with infectious mononucleosis, providing a model for studying these proc

169 Three presented with EBV infectious mononucleosis requiring hospitalization, 1 had chronic a

170 ned from donors with a history of infectious mononucleosis, showed diminished survival in culture wit

171 ms are of limited value for the diagnosis of mononucleosis; sore throat and fatigue are sensitive (ra

172 is significantly increases the likelihood of mononucleosis (summary LR, 11.4 [95% CI, 2.7-35] for aty

173 sk of MS increases markedly after infectious mononucleosis (symptomatic primary EBV infection) and wi

174 mary infections, including 2 with infectious mononucleosis syndrome.

175 ngs being more protective against infectious mononucleosis than older siblings.

176 ultifocal choroiditis following EBV-positive mononucleosis that demonstrated a dramatic clinical resp

177 ral MFC following an episode of EBV positive mononucleosis that showed a dramatic response to immunos

178 mola and Kaarianinen (3) first described CMV mononucleosis, the principal presentation of previously

179 iteria for CFS 6 months following infectious mononucleosis; the figure was 7% at 12 months and 4% at

180 to nasopharyngeal carcinoma, from infectious mononucleosis to Hodgkin's disease (HD) and Burkitt's ly

181 ge from the fairly benign disease infectious mononucleosis to life-threatening cancer.

182 from asymptomatic viremia through infectious mononucleosis to posttransplant lymphoproliferative diso

183 Epstein-Barr virus (EBV) causes infectious mononucleosis, triggers multiple sclerosis, and is assoc

184 Prior infectious mononucleosis was associated with increased odds of MS i

185 A history of infectious mononucleosis was negatively associated with NHL risk (O

186 eran-reported physician-diagnosed infectious mononucleosis were associated with CMI among deployed ve

187 hat the majority of patients with infectious mononucleosis were infected with multiple strains of EBV

188 and carried a high risk of severe infectious mononucleosis when homozygous.

189 Unlike acute infectious mononucleosis, wherein EBV establishes lifelong infectio